Med Op Health

Med-Op Health is a specialized healthcare company focused on the development and distribution of ocular nutraceuticals, primarily under the MaxiVision brand. The company's product portfolio is designed to support macular health and provide nutritional support for patients managing age-related macular degeneration (AMD) and dry eye syndrome. Founded by eye care professionals, Med-Op Health emphasized evidence-based formulations containing high concentrations of lutein, zeaxanthin, and other key antioxidants. In December 2023, Bausch + Lomb acquired the assets of Med-Op Health to strengthen its position in the ophthalmic supplement market. The acquisition integrated the MaxiVision line into Bausch + Lomb's broader consumer healthcare offerings, ensuring continued access to these specialized formulations for eye care practitioners and their patients.